Literature DB >> 20044972

Mitochondrial ion transport pathways: role in metabolic diseases.

Ariel R Cardoso1, Bruno B Queliconi, Alicia J Kowaltowski.   

Abstract

Mitochondria are the central coordinators of energy metabolism and alterations in their function and number have long been associated with metabolic disorders such as obesity, diabetes and hyperlipidemias. Since oxidative phosphorylation requires an electrochemical gradient across the inner mitochondrial membrane, ion channels in this membrane certainly must play an important role in the regulation of energy metabolism. However, in many experimental settings, the relationship between the activity of mitochondrial ion transport and metabolic disorders is still poorly understood. This review briefly summarizes some aspects of mitochondrial H+ transport (promoted by uncoupling proteins, UCPs), Ca2+ and K+ uniporters which may be determinant in metabolic disorders.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044972     DOI: 10.1016/j.bbabio.2009.12.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Redox regulation of the mitochondrial K(ATP) channel in cardioprotection.

Authors:  Bruno B Queliconi; Andrew P Wojtovich; Sergiy M Nadtochiy; Alicia J Kowaltowski; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2010-11-20

Review 2.  Physiology of potassium channels in the inner membrane of mitochondria.

Authors:  Ildikò Szabò; Luigi Leanza; Erich Gulbins; Mario Zoratti
Journal:  Pflugers Arch       Date:  2011-11-18       Impact factor: 3.657

3.  The fundamental unit of pain is the cell.

Authors:  David B Reichling; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2013-12       Impact factor: 6.961

Review 4.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

5.  A structurally simplified analogue of geldanamycin exhibits neuroprotective activity.

Authors:  Manikandadas M Madathil; Omar M Khdour; Jennifer Jaruvangsanti; Sidney M Hecht
Journal:  ACS Med Chem Lett       Date:  2013-07-25       Impact factor: 4.345

6.  Impairment of brain mitochondrial charybdotoxin- and ATP-insensitive BK channel activities in diabetes.

Authors:  E Noursadeghi; A Jafari; R Saghiri; R Sauve; A Eliassi
Journal:  Neuromolecular Med       Date:  2014-10-26       Impact factor: 3.843

Review 7.  Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases.

Authors:  Shane L Rea; Brett H Graham; Eiko Nakamaru-Ogiso; Adwitiya Kar; Marni J Falk
Journal:  Dev Disabil Res Rev       Date:  2010

8.  Administration of pioglitazone alone or with alogliptin delays diabetes onset in UCD-T2DM rats.

Authors:  Bethany P Cummings; Ahmed Bettaieb; James L Graham; Kimber Stanhope; Fawaz G Haj; Peter J Havel
Journal:  J Endocrinol       Date:  2014-03-13       Impact factor: 4.286

Review 9.  Targeting malignant mitochondria with therapeutic peptides.

Authors:  Jonathan E Constance; Carol S Lim
Journal:  Ther Deliv       Date:  2012-08

Review 10.  Mitochondrial ion channels/transporters as sensors and regulators of cellular redox signaling.

Authors:  Jin O-Uchi; Shin-Young Ryu; Bong Sook Jhun; Stephen Hurst; Shey-Shing Sheu
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.